Genmab A (GMAB) Payables (2025 - 2026)

Genmab A (GMAB) Payables (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.52 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 88.42 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 470.30 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.05 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 35.57 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 108.02 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 428.93 Mn
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 294.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 294.00 Mn
Dec 31, 2025 273.00 Mn